Literature DB >> 33537089

Organ-organ communication: The liver's perspective.

Fei Wang1, Kwok-Fai So2,3, Jia Xiao4, Hua Wang5,6.   

Abstract

Communication between organs participates in most physiological and pathological events. Owing to the importance of precise coordination among the liver and virtually all organs in the body for the maintenance of homeostasis, many hepatic disorders originate from impaired organ-organ communication, resulting in concomitant pathological phenotypes of distant organs. Hepatokines are proteins that are predominantly secreted from the liver, and many hepatokines and several signaling proteins have been linked to diseases of other organs, such as the heart, muscle, bone, and eyes. Although liver-centered interorgan communication has been proposed in both basic and clinical studies, to date, the regulatory mechanisms of hepatokine production, secretion, and reciprocation with signaling factors from other organs are obscure. Whether other hormones and cytokines are involved in such communication also warrants investigation. Herein, we summarize the current knowledge of organ-organ communication phenotypes in a variety of diseases and the possible involvement of hepatokines and/or other important signaling factors. This provides novel insight into the underlying roles and mechanisms of liver-originated signal transduction and, more importantly, the understanding of disease in an integrative view. © The author(s).

Entities:  

Keywords:  Cytokine; Disease mechanism.; Hepatokine; Liver; Organ communication

Mesh:

Substances:

Year:  2021        PMID: 33537089      PMCID: PMC7847667          DOI: 10.7150/thno.55795

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.556


  179 in total

1.  Hepcidin Deficiency Protects Against Atherosclerosis.

Authors:  Rajeev Malhotra; Florian Wunderer; Hanna J Barnes; Aranya Bagchi; Mary D Buswell; Caitlin D O'Rourke; Charles L Slocum; Clara D Ledsky; Kathryn M Peneyra; Haakon Sigurslid; Benjamin Corman; Kimberly B Johansson; David K Rhee; Kenneth D Bloch; Donald B Bloch
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

2.  Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection.

Authors:  Dana D Byrne; Craig W Newcomb; Dena M Carbonari; Melissa S Nezamzadeh; Kimberly B F Leidl; Maximilian Herlim; Yu-Xiao Yang; Sean Hennessy; Jay R Kostman; Mary B Leonard; A Russell Localio; Vincent Lo Re
Journal:  J Hepatol       Date:  2014-04-05       Impact factor: 25.083

3.  Role of the spleen in liver regeneration in relation to transforming growth factor-β1 and hepatocyte growth factor.

Authors:  Sang Chul Lee; Hye Jin Jeong; Byung-Jo Choi; Say-June Kim
Journal:  J Surg Res       Date:  2015-02-19       Impact factor: 2.192

Review 4.  The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance.

Authors:  Matthew J Watt; Paula M Miotto; William De Nardo; Magdalene K Montgomery
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

5.  Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease.

Authors:  Ozgur Pirgon; Huseyin Bilgin; Ismet Tolu; Dursun Odabas
Journal:  Clin Endocrinol (Oxf)       Date:  2011-08       Impact factor: 3.478

6.  Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production.

Authors:  Penny Y T Wang; Liora Caspi; Carol K L Lam; Madhu Chari; Xiaosong Li; Peter E Light; Roger Gutierrez-Juarez; Michelle Ang; Gary J Schwartz; Tony K T Lam
Journal:  Nature       Date:  2008-04-09       Impact factor: 49.962

7.  New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells.

Authors:  W Li; C S Kuhr; X X Zheng; K Carper; A W Thomson; J D Reyes; J D Perkins
Journal:  Am J Transplant       Date:  2008-06-12       Impact factor: 8.086

8.  Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore.

Authors:  M D Teleman; C B E Chee; A Earnest; Y T Wang
Journal:  Int J Tuberc Lung Dis       Date:  2002-08       Impact factor: 2.373

9.  Pancreatitis is an FGF21-deficient state that is corrected by replacement therapy.

Authors:  Genaro Hernandez; Ting Luo; Tanveer A Javed; Li Wen; Michael A Kalwat; Kevin Vale; Farah Ammouri; Sohail Z Husain; Steven A Kliewer; David J Mangelsdorf
Journal:  Sci Transl Med       Date:  2020-01-08       Impact factor: 17.956

10.  Hepatokine α1-Microglobulin Signaling Exacerbates Inflammation and Disturbs Fibrotic Repair in Mouse Myocardial Infarction.

Authors:  Daihiko Hakuno; Masahiro Kimura; Shinji Ito; Junko Satoh; Yasuhiro Nakashima; Takahiro Horie; Yasuhide Kuwabara; Masataka Nishiga; Yuya Ide; Osamu Baba; Hitoo Nishi; Tetsushi Nakao; Tomohiro Nishino; Fumiko Nakazeki; Satoshi Koyama; Ritsuko Hanada; Ruiz R Randolph; Jin Endo; Takeshi Kimura; Koh Ono
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

View more
  5 in total

Review 1.  Beyond the Liver: Liver-Eye Communication in Clinical and Experimental Aspects.

Authors:  Tian-Hao Yuan; Zhen-Sheng Yue; Guo-Heng Zhang; Lin Wang; Guo-Rui Dou
Journal:  Front Mol Biosci       Date:  2021-12-24

Review 2.  Crosstalk between adipose tissue and the microbiota-gut-brain axis in metabolic diseases.

Authors:  Ziwei Yu; Yuting Wang; Zhi Yu; Mengjiang Lu; Bin Xu
Journal:  Int J Biol Sci       Date:  2022-02-07       Impact factor: 6.580

3.  Frontiers in metabolic physiology grand challenges.

Authors:  John D Imig
Journal:  Front Physiol       Date:  2022-08-10       Impact factor: 4.755

Review 4.  Hepatic FGF21: Its Emerging Role in Inter-Organ Crosstalk and Cancers.

Authors:  Yue Sui; Jianping Chen
Journal:  Int J Biol Sci       Date:  2022-10-03       Impact factor: 10.750

5.  A Comparison of Gene Expression Profiles of Rat Tissues after Mild and Short-Term Calorie Restrictions.

Authors:  Kenji Saito; Maiko Ito; Takuya Chiba; Huijuan Jia; Hisanori Kato
Journal:  Nutrients       Date:  2021-06-30       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.